Home › NDC Lookup › Ingredients › Clindamycin Hydrochloride › 65862-0185-01
💊image loading
(from DailyMed)

Clindamycin Hydrochloride 150 mg Capsule, 100-count — NDC 65862-185-01 (Billing 65862-0185-01)

by Aurobindo Pharma Limited · 100 CAPSULE in 1 BOTTLE

This is a package of 100 capsules of Clindamycin Hydrochloride 150 mg Capsule from Aurobindo Pharma Limited, marketed since Aug 2009 and currently FDA-listed; retail pharmacies pay about $0.1028 per capsule (NADAC). It is the main listing for this product, which comes in 4 package sizes.

NDC 65862-0185-01
🏷️ FDA NDC (as labeled) 65862-185-01 billing pads the product segment with a zero
This package
Contains100-count Cost per ea$0.1028 NADAC Per package$10.28 / 100 capsules Pack sizes4 compare ↓
Also priced by: Medicaid pays $0.2707/unit · Part D plans $0.1397/unit — full pricing hub ↓
Main listing for product 65862-185 · Also comes in: 500 capsules 65862-185-05 2000 capsules 65862-185-22 40000 capsules 65862-185-40
Rx only Generic On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Oct 8, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 65862-185-01 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
65862 labeler · 185 product · 01 package
Listing certified through
Dec 31, 2027
Billing quantity
100 EA per package
Barcode (UPC-A, from the NDC)
3 6586218501 3
Medicaid fills, this package
52,562 prescriptions in the last four reported quarters
FDA record last changed
Oct 8, 2026
⚠️
Other active recalls for Clindamycin Hydrochloride (different manufacturers) — 1 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Mar 13, 2025 — CGMP Deviations (Glenmark Pharmaceuticals Inc., USA) · FDA recall D-0344-2025
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 65862-185-01
Product NDC 65862-185
11-digit billing NDC 65862018501
NCPDP billing unit EA — each (per item)
Application # ANDA065442
SPL Set ID b7173baa-2b39-4c31-82d4-839ac362e190
Established class (EPC) Lincosamide Antibacterial
Physiologic effect Decreased Sebaceous Gland Activity; Neuromuscular Blockade
Chemical class Lincosamides
DEA schedule Non-controlled
Marketing category ANDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2009-08-26
Route ORAL
Dosage form CAPSULE
Substance CLINDAMYCIN HYDROCHLORIDE
TE code (Orange Book) AB · RLD · RS

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 009339
GCN 40830
HICL code 004044
Ingredient (HICL) Clindamycin Hcl
HIC1 code W
Therapeutic class — broad (HIC1) Anti-Infecting Agents
HIC2 code W1
Therapeutic class — intermediate (HIC2) Antibiotics
HIC3 code W1K
Therapeutic class — specific (HIC3) Lincosamide Antibiotics
AHFS code 08:12.28.20
AHFS class Lincomycin Antibiotics
FDB label name CLINDAMYCIN HCL 150 MG CAPSULE
FDB brand name Clindamycin Hcl
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 009339
  • GCN: 40830
  • HICL (First Databank): 004044
  • AHFS class code: 08:12.28.20
Why two NDCs? The FDA registers this code as 65862-185-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 65862-0185-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name CLINDAMYCIN HCL 150 MG CAPSULE Ingredient Clindamycin Hcl
📗 Our plain-language guide HelloPharmacist
  • It treats serious bacterial infections, such as anaerobic infections, skin, lung, abdominal, gynecological, and bone and joint infections, depending on the product. It is often use...
  • Swallow them with a full glass of water and stay upright for at least 30 minutes afterward. This helps prevent irritation of your throat. Take it as often as your prescriber says a...
  • Rash, nausea, vomiting, stomach pain and itching are among the more commonly reported effects. Call your doctor right away if you get severe, watery or bloody diarrhea, even weeks...
  • What side effects are normal, and when should I call you?
📖 Read our full Clindamycin guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
7
Nutrient depletion considerations

Clindamycin may be associated with lower levels of 7 nutrients — worth a chat with your pharmacist, not a cause for alarm.

🧪 Full Clindamycin nutrient depletion report →
An association is not a deficiency. Educational only — don't start or stop anything without professional guidance.
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.103 $10.28 / 100 capsules
Medicaid paysCMS SDUD · 12 mo $0.2707 $27.07 / 100 capsules
Medicare drug plans payPart D · Q2 2026 $0.1397 $13.97 / 100 capsules
NADAC price history (per ea) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.125 $0.099
▼ Down 18% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
65862-0185-01 You're viewing this Main listing 100 CAPSULE in 1 BOTTLE $0.1028 / ea $10.28 2009-08-26 — Active
65862-0185-05 65862-185-05 500 CAPSULE in 1 BOTTLE $0.1028 / ea $51.40 2009-08-26 — Active
65862-0185-22 65862-185-22 2000 CAPSULE in 1 BAG — — — — Active
65862-0185-40 65862-185-40 40000 CAPSULE in 1 BAG — — — — Active

You're viewing the smallest of 4 pack sizes for this product.

This pack has the lowest per-ea cost of the 2 priced pack sizes ($0.1028 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 100% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This is a 100-count package — 100 capsule in 1 bottle.
How does this package differ from NDC 65862-0185-05?
Both are Clindamycin Hydrochloride 150 mg Capsule — the drug itself is identical. This page's package is the 100-count one, while NDC 65862-0185-05 is the 500 capsules package.
What NDC number is used to bill for this package of Clindamycin Hydrochloride 150 mg Capsule?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Clindamycin hydrochloride 150 mg 00904-5959-61 Major 100 capsules $0.103 AB Availability likely —
Clindamycin Hydrochloride 150 mg 42571-0251-01 Micro 100 capsules $0.103 AB Availability likely —
clindamycin hydrochloride 150 mg 59762-3328-01 Mylan 100 capsules $0.103 AB Discontinued —
Clindamycin Hydrochloride 150 mg 62135-0765-01 Chartwell 100 capsules $0.103 — Availability likely —
Clindamycin hydrochloride 150 mg 63304-0692-01 Sun 100 capsules $0.103 AB Availability likely —
Clindamycin Hydrochloride 150 mgthis 65862-0185-01 Aurobindo 100 capsules $0.103 AB Availability likely —
Clindamycin Hydrochloride 150 mg 68084-0243-01 American 100 capsules $0.103 AB Availability likely —
Clindamycin Hydrochloride 150 mg 68462-0143-01 GLENMARK 100 capsules $0.103 AB Availability likely —
Cleocin Hydrochloride 150 mg 00009-0225-02 Pharmacia 100 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 50090-0443-00 A-S 30 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 50090-1985-00 A-S 30 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 50090-4661-00 A-S 30 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 50090-7007-00 A-S 100 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 50090-7374-00 A-S 30 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 51407-0373-01 Golden 100 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 51655-0710-52 Northwind 30 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 51655-0964-52 Northwind 30 capsules — AB Discontinued —
Clindamycin hydrochloride 150 mg 55154-7276-00 Cardinal 10 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 60760-0487-28 St. 28 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 60760-0828-28 ST. 28 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 63187-0247-20 Proficient 20 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 68071-2286-04 NuCare 4 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 68071-2372-01 NuCare 100 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 68071-3582-01 NuCare 21 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 68071-3657-01 NuCare 100 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 68071-3681-04 NuCare 4 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 68071-3939-06 NuCare 6 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 68071-4335-00 NuCare 4 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 68071-5189-01 NuCare 21 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 68788-8558-00 Preferred 12 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 70518-4353-00 REMEDYREPACK 30 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 70518-4583-00 REMEDYREPACK 30 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 71335-0200-00 Bryant 40 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 71335-1489-00 Bryant 40 capsules — AB Discontinued —
Clindamycin Hydrochloride 150 mg 71335-2623-00 Bryant 40 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 72789-0180-04 PD-Rx 4 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 73614-0204-03 Brisk 30 capsules — AB FDA listed —
Clindamycin Hydrochloride 150 mg 76420-0616-01 Asclemed 100 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 87441-0005-01 Unit 30 capsules — AB FDA listed —
Clindamycin hydrochloride 150 mg 85534-0087-00 HAWAII 8 capsules — AB FDA listed —
About this product: this is a generic version of the medicine. FDA equivalence ratings are shown when available, and other versions are listed above, least expensive first.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2009
On the market since
Aug 2009
📍
2026
Currently FDA-listed
17 years listed
🔓
·
Generic on the market
this product is a generic
✅This is a generic drug

This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Clindamycin inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAurobindo Pharma Limited
Application holderAUROBINDO PHARMA LTD
FDA applicationANDA065442 (ANDA)
Labeler code65862
First marketedAug 2009
Product typeHuman Prescription Drug
Portfolio1,464 products on file

More NDCs from Aurobindo Pharma Limited labeler code 65862

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
📄 FDA label
📄 FDA label 19 words ▾

No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q4 2025 · 4 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
52.6K
Units reimbursed last 4 qtrs
2.3M
Gross reimbursed last 4 qtrs
$629K
Avg / prescription
$11.97
Avg / unit
$0.2707
Latest quarter Q4 2025
12.9KRx
Medicaid pays / ea
$0.2707
gross reimbursed
vs
NADAC / ea
$0.1028
acquisition cost
=
Spread
+$0.1679
+163% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
43% FFS 57% MCO
Fee-for-service · 22,733 Rx Managed care · 29,829 Rx
State Medicaid map
Alaska: 1,998 units · 273 per 100k residents AK Maine: 105,398 units · 7,555 per 100k residents ME Washington: 26,329 units · 337 per 100k residents WA Idaho: 6,978 units · 355 per 100k residents ID Montana: 4,662 units · 412 per 100k residents MT North Dakota: 540 units · 69.0 per 100k residents ND Minnesota: 25,982 units · 453 per 100k residents MN Wisconsin: 69,508 units · 1,176 per 100k residents WI Michigan: 126,515 units · 1,260 per 100k residents MI New York: 81,907 units · 419 per 100k residents NY Vermont: 7,685 units · 1,188 per 100k residents VT New Hampshire: 8,912 units · 636 per 100k residents NH Oregon: 21,549 units · 509 per 100k residents OR Nevada: 25,269 units · 791 per 100k residents NV Wyoming: 1,206 units · 207 per 100k residents WY South Dakota: 1,715 units · 187 per 100k residents SD Iowa: 40,706 units · 1,269 per 100k residents IA Illinois: 118,985 units · 948 per 100k residents IL Indiana: 19,603 units · 286 per 100k residents IN Ohio: 126,527 units · 1,074 per 100k residents OH Pennsylvania: 26,822 units · 207 per 100k residents PA New Jersey: 34,074 units · 367 per 100k residents NJ Massachusetts: 24,014 units · 343 per 100k residents MA California: 303,283 units · 778 per 100k residents CA Utah: 3,787 units · 111 per 100k residents UT Colorado: 58,274 units · 991 per 100k residents CO Nebraska: 17,850 units · 902 per 100k residents NE Missouri: 79,173 units · 1,278 per 100k residents MO Kentucky: 72,349 units · 1,599 per 100k residents KY West Virginia: 37,093 units · 2,096 per 100k residents WV Virginia: 25,299 units · 290 per 100k residents VA Maryland: 28,645 units · 464 per 100k residents MD Connecticut: 17,869 units · 494 per 100k residents CT Rhode Island: 12,695 units · 1,159 per 100k residents RI Arizona: 32,853 units · 442 per 100k residents AZ New Mexico: 42,813 units · 2,025 per 100k residents NM Kansas: 14,174 units · 482 per 100k residents KS Arkansas: 16,851 units · 549 per 100k residents AR Tennessee: 123,291 units · 1,730 per 100k residents TN North Carolina: 126,577 units · 1,168 per 100k residents NC South Carolina: 9,212 units · 171 per 100k residents SC Delaware: 15,042 units · 1,459 per 100k residents DE Oklahoma: 41,053 units · 1,013 per 100k residents OK Louisiana: 152,795 units · 3,341 per 100k residents LA Mississippi: 27,276 units · 928 per 100k residents MS Alabama: 27,800 units · 544 per 100k residents AL Georgia: 7,234 units · 65.6 per 100k residents GA D.C.: 394 units · 58.0 per 100k residents DC Hawaii: 2,385 units · 166 per 100k residents HI Texas: 52,703 units · 173 per 100k residents TX Florida: 66,322 units · 293 per 100k residents FL
Units reimbursed · per 100k residents
58.07,555
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Maine 7,555 /100k
2 Louisiana 3,341 /100k
3 West Virginia 2,096 /100k
4 New Mexico 2,025 /100k
5 Tennessee 1,730 /100k
6 Kentucky 1,599 /100k
7 Delaware 1,459 /100k
8 Missouri 1,278 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
100 capsules this page65862-0185-01 49,835 Rx · $590,369
500 capsules65862-0185-05 No Medicaid data
2000 capsules65862-0185-22 No Medicaid data
40000 capsules65862-0185-40 No Medicaid data
Drug total (last 4 qtrs): 49,835 Rx · 2,195,363 units · $590,369 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.
← 65862-0177-05 · Aurobindo 65862-0186-01 · Aurobindo →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.